Newby AC[au] - Search Results

Year	Number of Results
1975	1
1976	1
1977	1
1978	3
1979	2
1980	2
1981	3
1982	3
1983	2
1984	5
1985	6
1986	3
1987	3
1988	6
1989	6
1990	9
1991	6
1992	9
1993	6
1994	6
1995	6
1996	8
1997	3
1998	6
1999	10
2000	8
2001	6
2002	11
2003	7
2004	2
2005	8
2006	10
2007	11
2008	10
2009	5
2010	5
2011	8
2012	5
2013	2
2014	7
2015	6
2016	10
2017	8
2018	1
2019	3
2020	2
2021	1
2022	1

1

Endothelium-derived relaxing factor.

Griffith TM, Lewis MJ, Newby AC, Henderson AH. Griffith TM, et al. Among authors: newby ac. J Am Coll Cardiol. 1988 Sep;12(3):797-806. doi: 10.1016/0735-1097(88)90324-5. J Am Coll Cardiol. 1988. PMID: 3042836 Free article. Review.

2

Andrew Hurst Henderson, 1930-2017.

Fraser AG, Newby AC. Fraser AG, et al. Among authors: newby ac. Eur Heart J. 2017 Oct 7;38(38):2865-2866. doi: 10.1093/eurheartj/ehx573. Eur Heart J. 2017. PMID: 31411677 No abstract available.

3

Metalloproteinases and vulnerable atherosclerotic plaques.

Newby AC. Newby AC. Trends Cardiovasc Med. 2007 Nov;17(8):253-8. doi: 10.1016/j.tcm.2007.09.001. Trends Cardiovasc Med. 2007. PMID: 18021934 Free PMC article. Review.

4

Endothelial erosion of plaques as a substrate for coronary thrombosis.

White SJ, Newby AC, Johnson TW. White SJ, et al. Among authors: newby ac. Thromb Haemost. 2016 Mar;115(3):509-19. doi: 10.1160/TH15-09-0765. Epub 2016 Jan 21. Thromb Haemost. 2016. PMID: 26791872 Review.

5

Macrophage heterogeneity in atherosclerotic plaques.

Johnson JL, Newby AC. Johnson JL, et al. Among authors: newby ac. Curr Opin Lipidol. 2009 Oct;20(5):370-8. doi: 10.1097/MOL.0b013e3283309848. Curr Opin Lipidol. 2009. PMID: 19741337 Free PMC article. Review.

6

Matrix metalloproteinase inhibition therapy for vascular diseases.

Newby AC. Newby AC. Vascul Pharmacol. 2012 May-Jun;56(5-6):232-44. doi: 10.1016/j.vph.2012.01.007. Epub 2012 Feb 1. Vascul Pharmacol. 2012. PMID: 22326338 Review.

7

Do metalloproteinases destabilize vulnerable atherosclerotic plaques?

Newby AC. Newby AC. Curr Opin Lipidol. 2006 Oct;17(5):556-61. doi: 10.1097/01.mol.0000245262.48258.b4. Curr Opin Lipidol. 2006. PMID: 16960505 Review.

8

Proteinases and plaque rupture: unblocking the road to translation.

Newby AC. Newby AC. Curr Opin Lipidol. 2014 Oct;25(5):358-66. doi: 10.1097/MOL.0000000000000111. Curr Opin Lipidol. 2014. PMID: 25089553 Review.

9

Metabolic vasodilatation: the role of adenosine.

Newby AC. Newby AC. Biochem Soc Trans. 1988 Aug;16(4):479-80. doi: 10.1042/bst0160479. Biochem Soc Trans. 1988. PMID: 3061847 Review. No abstract available.

10

Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP.

Smith SA, Newby AC, Bond M. Smith SA, et al. Among authors: newby ac. Cells. 2019 Nov 16;8(11):1447. doi: 10.3390/cells8111447. Cells. 2019. PMID: 31744111 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results